恒瑞医药(01276.HK)：截至11月30日累计回购889.87万股
Ge Long Hui·2025-12-02 11:49

Core Viewpoint - Heng Rui Medicine (01276.HK) has announced a share repurchase plan, indicating a strategic move to enhance shareholder value through buybacks [1] Summary by Categories Share Repurchase Details - As of November 30, 2025, the company has repurchased a total of 8.8987 million shares, which represents 0.13% of the total share capital [1] - The highest purchase price was RMB 70.00 per share, while the lowest was RMB 59.32 per share [1] - The total amount paid for the repurchased shares is RMB 595.2163 million, excluding transaction fees [1]